Abstract
BackgroundAdoptive T-cell transfer has become an attractive therapeutic approach for hematological malignancies but shows poor activity against large and heterogeneous solid tumors. Interleukin-12 (IL-12) exhibits potent antitumor efficacy against solid...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have